COST UTILITY ANALYSIS OF REPLACING POSTERIOR TEETH
COST UTILITY ANALYSIS OF REPLACING POSTERIOR TEETH
批准号:
2458649
负责人:
Daniel A Shugars
金额:
$16.17万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1999-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nearly 30% of 35-60 years-olds in the U.S. have experienced tooth
extraction resulting in spaces between remaining teeth. Treatment of this
condition, the bounded edentulous space, costs in excess of $2.7 billion
annually. There are five alternative treatment strategies for the
condition, but their overall costs and consequences are not known. The
sparse information describing clinical outcomes of the alternative
treatments, coupled with the absence of any information about patient
preferences for these treatments has resulted in a situation where
several million substantive treatment decisions are based each year on
little more than dentists' subjective impressions of effectiveness.
This proposal describes cost-effectiveness and cost-utility analyses of
the five alternative treatment strategies for a bounded edentulous space.
The analyses will be based on Markov models to accommodate the complex
set of recurring complications that accompanies most of the alternative
treatments. Because the clinical outcomes of these alternative treatments
are poorly defined, transitional probabilities for all health states in
the Markov model will be determined through retrospective analyses of
treatment records in four large provider organizations and data form a
longitudinal epidemiology study, supplemented by information from a meta-
analysis of the literature. Patient utilities for use in the cost-utility
analyses will also be collected, and differences in utilities among
patients experienced and not experienced with the alternative treatments
will be examined. For the cost-effectiveness analysis, effectiveness is
measured in terms of "treatment survival year." The cost-utility analysis
will use a version of the same measure that has been "quality adjusted"
for patient preferences.
The results of the analyses will be useful in shared-decision making by
patients and dentists concerning the replacement of a posterior tooth.
Just as importantly, the results will represent the first step in the
development of practice guidelines for replacement of a lost tooth, the
most complex and expensive treatment routinely performed by general
dentists. More broadly, the information will be important to the
determination of appropriate dental health benefits by public and private
purchases regardless of the exact outcome of any health care reform.
Finally, because tooth loss is a terminal event in any dental treatment
sequence, the results of these analyses are vital to virtually all other
analyses of cost, effectiveness, and utility of dental treatment.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Survival rates of teeth adjacent to treated and untreated posterior bounded edentulous spaces.
治疗和未治疗的后牙无牙间隙附近牙齿的存活率。
DOI:
10.14219/jada.archive.1998.0383
发表时间:
1998
期刊:
Journal of the American Dental Association (1939)
影响因子:
--
作者:
[Shugars,DA, Bader,JD, White,BA, Scurria,MS, HaydenJr,WJ, Garcia,RI]
通讯作者:
Garcia,RI
Xylitol Adult Caries Trial (X-ACT)--UNC Clinical Center
-
批准号:7470153
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2006
-
负责人:Daniel A Shugars
-
依托单位:
Xylitol Adult Caries Trial (X-ACT)--UNC Clinical Center
-
批准号:7197511
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2006
-
负责人:Daniel A Shugars
-
依托单位:
Xylitol Adult Caries Trial (X-ACT)--UNC Clinical Center
-
批准号:7658186
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2006
-
负责人:Daniel A Shugars
-
依托单位:
Xylitol Adult Caries Trial (X-ACT)--UNC Clinical Center
-
批准号:7886781
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2006
-
负责人:Daniel A Shugars
-
依托单位:
Xylitol Adult Caries Trial (X-ACT)--UNC Clinical Center
-
批准号:7289839
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2006
-
负责人:Daniel A Shugars
-
依托单位:
COST UTILITY ANALYSIS OF REPLACING POSTERIOR TEETH
-
批准号:2133243
-
项目类别:
-
资助金额:$15.6万
-
财政年份:1995
-
负责人:Daniel A Shugars
-
依托单位:
COST UTILITY ANALYSIS OF REPLACING POSTERIOR TEETH
-
批准号:2133242
-
项目类别:
-
资助金额:$14.94万
-
财政年份:1995
-
负责人:Daniel A Shugars
-
依托单位:
海外基金